SKB BIO Announces Investment in Structured Deposit Product

Stock News
Jun 03

SKB BIO (HKEX: 06990) has disclosed a new financial transaction. On June 3, 2026, the company entered into the China Zheshang Bank Structured Deposit Agreement IV. Under this agreement, SKB BIO has agreed to subscribe for a structured deposit from China Zheshang Bank with a principal amount of RMB 300 million.

As of the date of this announcement, the total outstanding principal amount of the company's wealth management products placed with China Zheshang Bank stands at RMB 590 million. This total comprises three specific structured deposits: (i) a RMB 100 million deposit under Structured Deposit Agreement II, details of which were provided in an April 2026 announcement; (ii) a RMB 190 million deposit under Structured Deposit Agreement III; and (iii) the newly announced RMB 300 million deposit under Structured Deposit Agreement IV.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10